Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17973952 | 0.71 | MAPT (0.42) | AKT1ALDH1A1ESR1ESR2 | |
| SCHEMBL17973969 | 0.68 | CA12 (0.31) | — | |
| SCHEMBL26774944 | 0.68 | ALDH1A1 (0.37) | ALDH1A1ESR1ESR2 | |
| SCHEMBL4296355 | 0.66 | AKT1 (0.47) | AKT1ALDH1A1 | |
| SCHEMBL16127134 | 0.64 | TSHR (0.37) | — | |
| SCHEMBL26767425 | 0.64 | CNR2 (0.39) | ALDH1A1ESR1ESR2 | |
| SCHEMBL22412614 | 0.63 | AKT1 (0.58) | AKT1 | |
| SCHEMBL10440177 | 0.63 | PTGS2 (0.37) | AKT1 | |
| SCHEMBL31085232 | 0.63 | TSHR (0.46) | — | |
| SCHEMBL2868026 | 0.62 | ESR1 (0.50) | ALDH1A1TAAR1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160222295-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME | DAXIN MATERIALS CORPORATION (TW) | 2016-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160222295-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME | ZYX, MLX, NPM1 | AKT1 1142/4885ALDH1A1 3163/4885PTPN1 2291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.